Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             344 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abbreviated cyclosporine pharmacokinetic profiling in clinical renal transplantation: from principles to practice Vathsala, A
 2001
 33 7-8 p. 3137-3139
3 p.
 artikel
2 Absence of acute rejection using basiliximab with triple immunosuppression in cadaveric kidney recipients in first three months Kandus, A.
 2001
 33 7-8 p. 3207-3208
2 p.
 artikel
3 Achieving clinical transplant tolerance: what are the hurdles? Salamam, A.D.
 2001
 33 7-8 p. 3038-3040
3 p.
 artikel
4 Advances in segmental liver transplantation: can we solve the donor shortage? Guarrera, J.V.
 2001
 33 7-8 p. 3451-3455
5 p.
 artikel
5 Aerobic ischemia by venous systemic O2 Persufflation (VSOP) during cold storage of predamaged livers: molecular impact and physiologic benefit Akbar, S.
 2001
 33 7-8 p. 3716-3717
2 p.
 artikel
6 Alloantigen recognition pathways and transplant tolerance Pettigrew, G.J.
 2001
 33 7-8 p. 3811-3813
3 p.
 artikel
7 Allogeneic stem cells, clinical transplantation, and the origins of regenerative medicine Strom, T.B.
 2001
 33 7-8 p. 3044-3049
6 p.
 artikel
8 Analysis of liver allograft rejection related genes using cDNA-microarrays in liver allograft specimen Tannapfel, A.
 2001
 33 7-8 p. 3283-3284
2 p.
 artikel
9 Analysis of neurologic complications within the first 30 days after orthotopic liver transplantation Boin, I.F.S.F
 2001
 33 7-8 p. 3695-3696
2 p.
 artikel
10 Ancient proteins and futuristic surgery: the role of complement in discordant xenograft rejection Winkler, M.
 2001
 33 7-8 p. 3862-3864
3 p.
 artikel
11 Angiotensin receptor antagonism in patients after renal transplantation: effects on glomerular function and tgf-β1 plasma levels Hetzel, G.R.
 2001
 33 7-8 p. 3370-3372
3 p.
 artikel
12 An impaired cardiodynamic phase contributes to the abnormal vo2 kinetics at exercise onset in both congestive heart failure and heart transplant patients but results from differing mechanisms M’Bouh, S
 2001
 33 7-8 p. 3543-3545
3 p.
 artikel
13 An oral formulation for intracellular adhesion molecules-1 antisense oligonucleotides Stepkowski, S.M.
 2001
 33 7-8 p. 3271-
1 p.
 artikel
14 A novel model of pig-to-monkey kidney xenotransplantation Wang, X.M.
 2001
 33 7-8 p. 3859-
1 p.
 artikel
15 Anti-CD25 prophylaxis allows steroid free kidney transplantation Weimar, W.
 2001
 33 7-8 p. 3176-3177
2 p.
 artikel
16 A pilot study comparing basiliximab and anti-thymocyte globulin as induction therapy in sensitized renal allograft recipients Mariat, C.
 2001
 33 7-8 p. 3192-3193
2 p.
 artikel
17 A pilot study of steroid withdrawal from kidney transplant recipients on sirolimus-cyclosporine a combination therapy Mahalati, K.
 2001
 33 7-8 p. 3232-3233
2 p.
 artikel
18 A single center experience with basiliximab induction therapy in renal transplantation Henry, M.L.
 2001
 33 7-8 p. 3178-3179
2 p.
 artikel
19 A single-centre experience with cyclosporine microemulsion versus tacrolimus in 100 randomized liver transplant recipients: midterm efficacy and safety Loinaz, C.
 2001
 33 7-8 p. 3439-3441
3 p.
 artikel
20 A study of cobra venom factor in ex vivo pig liver perfusion model Shen, S.Q.
 2001
 33 7-8 p. 3860-3861
2 p.
 artikel
21 A study of human DAF, cd59, MCP transgene in xenotransplantation Chen, S.
 2001
 33 7-8 p. 3851-3852
2 p.
 artikel
22 2001: a transplant odyssey Kahan, B.D.
 2001
 33 7-8 p. 3025-3026
2 p.
 artikel
23 2001, a transplant odyssey: Epilogue Kahan, B.D.
 2001
 33 7-8 p. 3875-
1 p.
 artikel
24 2001: a transplant odyssey opening speech Rosenberg, T.
 2001
 33 7-8 p. 3030-3031
2 p.
 artikel
25 Attitudes of 15-year-old children toward cadaveric organ donation and transplantation Orlic, P
 2001
 33 7-8 p. 3615-3616
2 p.
 artikel
26 Author index 2001
 33 7-8 p. 3877-3884
8 p.
 artikel
27 Autotransplantation of heart for repair of left ventricular rupture after mitral valve replacement Wei, J.
 2001
 33 7-8 p. 3553-3554
2 p.
 artikel
28 Basiliximab can be administered safely and effectively in a single dose on day 1 postrenal transplantation in patients receiving triple therapy with azathioprine Matl, I
 2001
 33 7-8 p. 3205-3206
2 p.
 artikel
29 Basiliximab versus ATG/ALG induction in pediatric renal transplants: comparison of herpes virus profile and rejection rates Acott, P.D
 2001
 33 7-8 p. 3180-3183
4 p.
 artikel
30 Benefits of cyclosporine microemulsion (Neoral) C2 monitoring are sustained at 1 year in de novo liver transplant recipients Lake, J.R.
 2001
 33 7-8 p. 3092-3093
2 p.
 artikel
31 Biologic behavior of carcinoid tumors in solid organ transplant recipients: the Israel Penn international transplant tumor registry experience Woodle, E.S.
 2001
 33 7-8 p. 3656-3657
2 p.
 artikel
32 Biopsy-proven resolution of steroid-resistant acute rejection with basiliximab therapy in a renal allograft recipient Goh, H.K.
 2001
 33 7-8 p. 3213-3214
2 p.
 artikel
33 Bone mineral density in kidney transplant recipients Kovac̆, D.
 2001
 33 7-8 p. 3668-3669
2 p.
 artikel
34 Bronchiolitis obliterans syndrome in transplanted patients: findings on spirometrically guided high-resolution computed tomography Ewert, R.
 2001
 33 7-8 p. 3576-3577
2 p.
 artikel
35 Can three-times-a-aay cyclosporine neoral avoid cylosporine toxicity in renal transplant recipients? a pharmacokinetic study Swart, N.
 2001
 33 7-8 p. 3140-3141
2 p.
 artikel
36 Carbon dioxide subtraction angiography for management of kidney transplant vascular complications Nicolini, A.
 2001
 33 7-8 p. 3388-3389
2 p.
 artikel
37 Cardiovascular and metabolic complications after liver transplantation: neoral- versus tacrolimus-based immunosuppression Risaliti, A.
 2001
 33 7-8 p. 3684-3685
2 p.
 artikel
38 Cardiovascular risk factors in recipients of successful kidney-pancreas transplantation Coppelli, A
 2001
 33 7-8 p. 3681-
1 p.
 artikel
39 Case-based reasoning algorithm for kidney transplant monitoring Fritsche, L
 2001
 33 7-8 p. 3331-3333
3 p.
 artikel
40 C2 blood levels in heart-transplanted patients immunosuppressed on a trough level-;based regimen Fiocchi, R.
 2001
 33 7-8 p. 3115-3116
2 p.
 artikel
41 CD4 and CD8 cytokine-producing T cells are transiently reduced following cyclosporine intake: maximal inhibition occurs at 2 hours coincidental with drug Cmax Mora, J.R.
 2001
 33 7-8 p. 3310-3312
3 p.
 artikel
42 Chemokines: reliable markers for diagnosis of rejection and inflammation following orthotopic liver transplantation Moench, Ch
 2001
 33 7-8 p. 3293-3294
2 p.
 artikel
43 Chronic allograft nephropathy: what can the biopsy tell us? Furness, P.N.
 2001
 33 7-8 p. 3357-3358
2 p.
 artikel
44 Chronic rejection: a significant predictor of poor outcome for recurrence IgA nephropathy Sumethkul, V.
 2001
 33 7-8 p. 3375-3376
2 p.
 artikel
45 Circulating adrenomedullin is increased after renal transplantation Geny, B.
 2001
 33 7-8 p. 3396-3397
2 p.
 artikel
46 Clinical islet transplant—state of the art Shapiro, A.M.J.
 2001
 33 7-8 p. 3502-3503
2 p.
 artikel
47 Clinical markers and modifiable cardiovascular risk factors after kidney transplantation Arias, M
 2001
 33 7-8 p. 3677-3678
2 p.
 artikel
48 Clinical validation of the banff 97 classification for the diagnosis of rejection in kidney transplant Palomar, R.
 2001
 33 7-8 p. 3309-
1 p.
 artikel
49 Comparative study of population pharmacokinetics upon switching of cyclosporine formulation from sandimmune to neoral in stable renal transplant patients Yoshida, K
 2001
 33 7-8 p. 3146-3147
2 p.
 artikel
50 Comparison of the efficacy in prevention of hepatitis B virus recurrence after liver transplantation between HBIG and lamivudine Lee, K.W
 2001
 33 7-8 p. 3643-3644
2 p.
 artikel
51 Comparison of trough level and C2 cyclosporine blood concentration monitoring in outpatient kidney transplant recipients Braun, F.
 2001
 33 7-8 p. 3108-3109
2 p.
 artikel
52 Construction of an optimal facility for clinical pancreatic islet isolation Rastellini, C.
 2001
 33 7-8 p. 3524-
1 p.
 artikel
53 Continuous subcutaneous insulin infusion in a patient with partial endocrine pancreatic graft function Giannarelli, R
 2001
 33 7-8 p. 3500-3501
2 p.
 artikel
54 Contractility, myocardial blood flow, and metabolic activity 24 hours after orthotopic heart transplantation from non-heart-beating donors: in vivo investigations in the Pig Model Martin, J
 2001
 33 7-8 p. 3739-3740
2 p.
 artikel
55 Control of risk factors for cardiovascular disease in long-term renal transplant recipients First, M.R.
 2001
 33 7-8 p. 3674-3675
2 p.
 artikel
56 Conversion from cyclosporine to tacrolimus for refractory acute rejection in pediatric kidney transplant recipients: a single-center experience Ferraresso, M.
 2001
 33 7-8 p. 3590-3591
2 p.
 artikel
57 Conversion from cyclosporine to tacrolimus prevents transplant function loss due to acute steroid-resistant or chronic rejection in renal allograft recipients Blume, C.
 2001
 33 7-8 p. 3161-3163
3 p.
 artikel
58 Conversion from tacrolimus to neoral in liver and kidney transplant recipients Ott, R
 2001
 33 7-8 p. 3166-3168
3 p.
 artikel
59 Conversion to neoral for tacrolimus-related adverse effects in liver transplant recipients and improvement in quality of life Tolba, R.H.
 2001
 33 7-8 p. 3446-3447
2 p.
 artikel
60 Conversion to rapamycin in renal allograft recipients with biopsy-proven calcineurin inhibitor-induced nephrotoxicity Diekmann, F.
 2001
 33 7-8 p. 3234-3235
2 p.
 artikel
61 Coronary angiography in heart donors: a necessity or a luxury? Grauhan, O.
 2001
 33 7-8 p. 3805-
1 p.
 artikel
62 Correlation of captopril magnetic resonance renogram and perfusion changes with severity of renal allograft artery stenosis Sharma, R.K.
 2001
 33 7-8 p. 3381-3382
2 p.
 artikel
63 Corticosteroids enhance hepatic injury following ischemia-reperfusion Sileri, P.
 2001
 33 7-8 p. 3712-
1 p.
 artikel
64 Cost-effectiveness of early living related segmental bowel transplantation as therapy for trauma-induced irreversible intestinal failure Cicalese, L.
 2001
 33 7-8 p. 3581-3582
2 p.
 artikel
65 Cost-minimization study comparing simulect versus thymoglobulin in renal transplant induction Lilliu, H
 2001
 33 7-8 p. 3197-3198
2 p.
 artikel
66 Covariates influencing outcomes of old cadaveric donor kidney transplants Bertoni, E
 2001
 33 7-8 p. 3798-3800
3 p.
 artikel
67 Creatinine clearance in recipients of kidneys from non-heart-beating donors Gok, M.A
 2001
 33 7-8 p. 3777-3778
2 p.
 artikel
68 CSA/MMF/steroids versus CSA/AZA/steroids with and without basiliximab in cadaveric kidney transplantation Boggi, U
 2001
 33 7-8 p. 3199-3200
2 p.
 artikel
69 C2 single-point sampling to evaluate cyclosporine exposure in long-term renal transplant recipients Citterio, F
 2001
 33 7-8 p. 3133-3136
4 p.
 artikel
70 Current status of heart and lung transplantation Barr, M.L.
 2001
 33 7-8 p. 3564-3565
2 p.
 artikel
71 Cyclosporine A: peak or trough level monitoring in renal transplant recipients? Wacke, R.
 2001
 33 7-8 p. 3122-3123
2 p.
 artikel
72 Cyclosporine-associated encephalopathy: a case report and literature review Chang, S.H.
 2001
 33 7-8 p. 3700-3701
2 p.
 artikel
73 Cyclosporine dose fractioning might affect renal function in stable heart transplanted patients Baraldo, M.
 2001
 33 7-8 p. 3151-3153
3 p.
 artikel
74 Cyclosporine level: which single-point estimation of drug level is the best? Sharma, R.
 2001
 33 7-8 p. 3124-3125
2 p.
 artikel
75 Cyclosporine microemulsion and tacrolimus are associated with decreased chronic allograft failure and improved long-term graft survival as compared to sandimmune Meier-Kriesche, H.U.
 2001
 33 7-8 p. 3422-3423
2 p.
 artikel
76 Cyclosporine neoral profiling in japanese renal transplant recipients Aikawa, A
 2001
 33 7-8 p. 3142-3145
4 p.
 artikel
77 Cyclosporine peak concentration in relation to the four-hour absorption phase in pediatric renal graft recipients Wigger, M.
 2001
 33 7-8 p. 3126-3127
2 p.
 artikel
78 Cyclosporine-triggered hemolytic-uremic syndrome in kidney graft recipients: a series of 12 cases Bren, A.F.
 2001
 33 7-8 p. 3691-3692
2 p.
 artikel
79 Cytokine release from liver grafts during cold ischemia Schenk, M.
 2001
 33 7-8 p. 3722-3723
2 p.
 artikel
80 Cytomegalovirus infection after liver transplantation using different prophylaxes Kornberg, A.
 2001
 33 7-8 p. 3624-3625
2 p.
 artikel
81 Death after graft loss: a novel endpoint for renal tranplantation Meier-Kriesche, H.-U
 2001
 33 7-8 p. 3405-3406
2 p.
 artikel
82 Death of alloreactive T cells sets the stage for immunoregulation to act Li, X.C.
 2001
 33 7-8 p. 3041-3043
3 p.
 artikel
83 Decreasing side effects of neoral through three-times-a-day protocol in chinese renal transplant patients Chen, Z.S
 2001
 33 7-8 p. 3156-3157
2 p.
 artikel
84 Dendritic cells, generated in vitro, are immunocompetent and very useful in the induction of specific cytotoxic T lymphocyte activity Hasel, T
 2001
 33 7-8 p. 3814-3815
2 p.
 artikel
85 De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine a sirolimus combination Langer, R.M.
 2001
 33 7-8 p. 3236-3237
2 p.
 artikel
86 De novo noncutaneous malignancies in heart transplantation: a single-centre 15-year experience and risk factor analysis Caforio, A.L.P.
 2001
 33 7-8 p. 3658-3659
2 p.
 artikel
87 Depressive symptoms and kidney transplant outcome Rocha, G.
 2001
 33 7-8 p. 3424-
1 p.
 artikel
88 Detection of cardiac myosin-specific autoimmunity in a model of chronic heart allograft rejection Rolls, H.K.
 2001
 33 7-8 p. 3821-3822
2 p.
 artikel
89 Development of transplantation in Turkey Haberal, M.
 2001
 33 7-8 p. 3027-3029
3 p.
 artikel
90 Differential activity of plasma and endoplasmic reticulum membrane Ca2+-ATPases in porcine hepatocytes Belous, A.E.
 2001
 33 7-8 p. 3720-3721
2 p.
 artikel
91 Differentiation of CMV-specific CD8POS T lymphocytes in primary CMV infection after renal transplantation ten Berge, I.J.M.
 2001
 33 7-8 p. 3630-
1 p.
 artikel
92 Disorders of coagulation unrelated to xenograft rejection following pig-to-cynomolgus kidney transplantation Loss, M.
 2001
 33 7-8 p. 3867-3868
2 p.
 artikel
93 Does previous thoracic surgery increase perioperative risk in lung transplantation? Hirt, S.W.
 2001
 33 7-8 p. 3572-3573
2 p.
 artikel
94 Does taking part in multiple clinical studies with new immunosuppressive agents affect the outcome of renal transplantation? Rigotti, P
 2001
 33 7-8 p. 3427-3428
2 p.
 artikel
95 Does the distribution of circulating CD4+CD28+, CD4+CD25+ T lymphocytes indicate subclinical rejection in patients in the early postoperative state of renal transplantation? Satoh, S
 2001
 33 7-8 p. 3301-3302
2 p.
 artikel
96 Donor and recipient risk factors and choice of immunosuppression determine long-term outcome in renal transplantation Mathew, T.H.
 2001
 33 7-8 p. 3400-3402
3 p.
 artikel
97 Duplex doppler follow-up of renal transplant artery stenosis in children Ponikvar, J.Buturović
 2001
 33 7-8 p. 3599-3601
3 p.
 artikel
98 Effect of antisense oligonucleotides for tissue factor on hepatic ischemia-reperfusion injury in the rat Nakamura, K.
 2001
 33 7-8 p. 3707-3708
2 p.
 artikel
99 Effect of apolipoprotein E and C-III polymorphisms on lipid profile and cardiovascular risk in renal transplant recipients Rodrigo, E.
 2001
 33 7-8 p. 3676-
1 p.
 artikel
100 Effect of cyclosporine and ischemia on experimental transplant arteriosclerosis Domı́nguez, J.
 2001
 33 7-8 p. 3735-3736
2 p.
 artikel
101 Effect of donor age on the outcome of one hla-haplotype mismatched living-related transplantation Kim, Y.W.
 2001
 33 7-8 p. 3793-3794
2 p.
 artikel
102 Effect of donor hepatitis c on liver graft survival Velidedeoglu, E.
 2001
 33 7-8 p. 3795-3796
2 p.
 artikel
103 Effect of ERL080A, RAD, and neoral on hamster-to-rat heart xenograft survival Zhu, T.
 2001
 33 7-8 p. 3871-3872
2 p.
 artikel
104 Effects of exercise training on specific immune parameters in transplant recipients Surgit, O.
 2001
 33 7-8 p. 3298-
1 p.
 artikel
105 Effects of mycophenolate mofetil and azathioprine on the erythropoietin production in renal transplant recipients Montanaro, D
 2001
 33 7-8 p. 3253-3255
3 p.
 artikel
106 Effects of mycophenolate mofetil in the development of systemic lupus erythematosus in (NZBxNZW)F1 mice Ramos, Ma.A.
 2001
 33 7-8 p. 3316-3317
2 p.
 artikel
107 Effects of pirfenidone on vascular smooth muscle cell proliferation and intimal hyperplasia following arterial balloon injury Waller, J.R
 2001
 33 7-8 p. 3816-3818
3 p.
 artikel
108 Efficacy and safety of antithymocyte globulin treatment of steroid-resistant acute rejection in kidney transplantation Bertoni, E.
 2001
 33 7-8 p. 3337-
1 p.
 artikel
109 Efficacy of C2 monitoring of cyclosporine neoral in adult liver transplantation: a comparative study Santoyo, J.
 2001
 33 7-8 p. 3096-3097
2 p.
 artikel
110 Emergency intra- and perioperative doppler after kidney transplantation—a guide for immediate surgical intervention Urbanc̆ic̆, A.
 2001
 33 7-8 p. 3320-3321
2 p.
 artikel
111 Enteric-coated mycophenolate sodium: results of two pivotal global multicenter trials Granger, D.K
 2001
 33 7-8 p. 3241-3244
4 p.
 artikel
112 Enteric coating of mycophenolate sodium: a rational approach to limit topical gastrointestinal lesions and extend the therapeutic index of mycophenolate Bjarnason, I.
 2001
 33 7-8 p. 3238-3240
3 p.
 artikel
113 Enzymatic digestion of α-gal antigens in pig organs by in vivo infusion of endo-β-galactosidase C Kobayashi, T.
 2001
 33 7-8 p. 3855-3856
2 p.
 artikel
114 Erythrocyte sodium lithium countertransport in heart transplantation Vareesangthip, K
 2001
 33 7-8 p. 3561-3563
3 p.
 artikel
115 Evaluation with enzyme-linked immunosorbent assay spot detection of the frequency of interferon-gamma-producing T cells in bronchoalveolar lavage is useful in identifying lung transplant patients at higher risk of acute rejection Meloni, F.
 2001
 33 7-8 p. 3286-3288
3 p.
 artikel
116 Experience with basiliximab in pediatric liver graft recipients Ganschow, R.
 2001
 33 7-8 p. 3606-3607
2 p.
 artikel
117 Factors influencing the discrepancy between donor and recipient glomerular filtration rate in kidney transplantation Arisi, L.
 2001
 33 7-8 p. 3377-3378
2 p.
 artikel
118 Feasibility of changing therapeutic cyclosporine monitoring from C0 to C2 in stable renal recipients: narrower coefficient of variation with C2 monitoring Chueh, S.-C.
 2001
 33 7-8 p. 3100-3101
2 p.
 artikel
119 First european combined heart, kidney, and pancreas transplantation 11 years after Mettauer, B.
 2001
 33 7-8 p. 3496-3498
3 p.
 artikel
120 Flow panel reactive antibody monitoring following heart transplantation Tambur, A.R.
 2001
 33 7-8 p. 3295-3297
3 p.
 artikel
121 FTY720: a new dimension in transplantation Kahan, B.D.
 2001
 33 7-8 p. 3081-3083
3 p.
 artikel
122 FTY720, a novel transplantation drug, modulates lymphocyte migratory responses to chemokines Chen, S
 2001
 33 7-8 p. 3057-3063
7 p.
 artikel
123 FTY720: dissection of membrane receptor-operated, stereospecific effects on cell migration from receptor-independent antiproliferative and apoptotic effects Brinkmann, V.
 2001
 33 7-8 p. 3078-3080
3 p.
 artikel
124 Functional reserve and hyperfiltration after cadaveric renal transplantation Bertoni, E.
 2001
 33 7-8 p. 3363-3364
2 p.
 artikel
125 Further suppression of immune response in renal allograft recipients infected with hepatitis C Rao, V.K
 2001
 33 7-8 p. 3645-
1 p.
 artikel
126 β-Galactosidase as a novel marker of ischaemic injury and a mechanism for viability assessment in liver transplantation St. Peter, S.D.
 2001
 33 7-8 p. 3753-3755
3 p.
 artikel
127 Gene expression patterns in lung rejection Hertz, M.I.
 2001
 33 7-8 p. 3566-3567
2 p.
 artikel
128 Generally increased, circulating endothelin can normalize after heart transplantation Piquard, F
 2001
 33 7-8 p. 3558-3560
3 p.
 artikel
129 Genetic modification for xenotransplantation: transgenics and clones d’Apice, A.J.F
 2001
 33 7-8 p. 3053-3054
2 p.
 artikel
130 Glucose intolerance and diabetes in recipients of kidney graft: comparison of old and new ADA and WHO criteria Aragona, M
 2001
 33 7-8 p. 3664-
1 p.
 artikel
131 GLY145ARG mutation emerging under HBIG treatment in patients with recurrent HBV after liver transplantation strongly reduces viral secretion Fischer, L.
 2001
 33 7-8 p. 3633-3636
4 p.
 artikel
132 Glycine reduces reperfusion injury in human liver transplantation: our first patients Schemmer, P
 2001
 33 7-8 p. 3750-3752
3 p.
 artikel
133 Graft endothelium and chronic allograft nephropathy: insight from in vitro trans-differentiation of smooth muscle cells induced by mismatched lymphocytes Amore, A.
 2001
 33 7-8 p. 3347-3348
2 p.
 artikel
134 Graft loss and death: changing causes after kidney transplantation Howard, R.J.
 2001
 33 7-8 p. 3416-
1 p.
 artikel
135 Graft vascular endothelium: its role in transplantation biology Paul, L.C.
 2001
 33 7-8 p. 3809-3810
2 p.
 artikel
136 Granzyme B inhibitor I reduces apoptotic cell death of allogeneic-transplanted hepatocytes in spleen Song, E
 2001
 33 7-8 p. 3274-3275
2 p.
 artikel
137 Growth following solid organ transplantation Fine, R.N.
 2001
 33 7-8 p. 3592-3594
3 p.
 artikel
138 Heart-lung-liver transplant for cystic fibrosis Wise, P.E
 2001
 33 7-8 p. 3568-3571
4 p.
 artikel
139 Hepatic outflow insults in living-related liver transplantation: by doppler sonography Huang, T.L.
 2001
 33 7-8 p. 3464-3465
2 p.
 artikel
140 Hepatocyte grafting as an alternative to liver transplant Carraresi, L.
 2001
 33 7-8 p. 3474-3476
3 p.
 artikel
141 HIV infection following transplantation: the South African experience Kahn, D.
 2001
 33 7-8 p. 3649-3650
2 p.
 artikel
142 HLA-DMB polymorphism in living-related kidney transplantation Fukuda, Y
 2001
 33 7-8 p. 3304-3308
5 p.
 artikel
143 HLA-identical renal transplant recipients: immunosuppression, long-term complications, and survival Peddi, V.R.
 2001
 33 7-8 p. 3411-3413
3 p.
 artikel
144 Hyperhomocysteinemia in renal transplant patients as independent cause of endothelial damage and cardiovascular disease Bertoni, E
 2001
 33 7-8 p. 3682-3683
2 p.
 artikel
145 Immunomonitoring of renal transplant recipients in the early posttransplant period by analysis of cytokine gene expression in peripheral blood mononuclear cells Gibbs, P.J.
 2001
 33 7-8 p. 3285-
1 p.
 artikel
146 Immunoregulatory T-Cells can mediate specific unresponsiveness to alloantigens in vivo Wood, K.J.
 2001
 33 7-8 p. 3829-3830
2 p.
 artikel
147 Immunosuppression and bone loss after transplantation Torregrosa, J.V.
 2001
 33 7-8 p. 3665-3667
3 p.
 artikel
148 Immunosuppression through blockade of transferrin receptor: mechanisms Rastellini, C.
 2001
 33 7-8 p. 3279-
1 p.
 artikel
149 Incidence and treatment of hyperhomocysteinemia after renal transplantation Zantvoort, F.A.
 2001
 33 7-8 p. 3679-3680
2 p.
 artikel
150 Increasing incidence of cytomegalovirus disease in indian renal transplant recipients on cyclosporine immunosuppression Sakhuja, V.
 2001
 33 7-8 p. 3631-3632
2 p.
 artikel
151 Induction versus noninduction protocols in anti-calcineurin-based immunosuppression Charpentier, B.
 2001
 33 7-8 p. 3334-3336
3 p.
 artikel
152 Influence of Ginkgo Biloba extract (EGB 761) on expression of EGR-1 mRNA and HSP-70 mRNA after warm ischemia in the rat liver Schutte, A.
 2001
 33 7-8 p. 3724-3725
2 p.
 artikel
153 Influence of recipient and donor age on long-term renal allograft function in an experimental model Tullius, S.G.
 2001
 33 7-8 p. 3345-3346
2 p.
 artikel
154 Initial neoral use for living-related partial liver transplantation: Its indication and limitation Yokoyama, I.
 2001
 33 7-8 p. 3131-3132
2 p.
 artikel
155 Insulin secretion from cultured islets encapsulated in immuno- and virus-protective capillaries Petersen, P.
 2001
 33 7-8 p. 3520-3522
3 p.
 artikel
156 Interaction between acute rejection and recipient age on long-term renal allograft survival Meier-Kriesche, H.-U.
 2001
 33 7-8 p. 3425-3426
2 p.
 artikel
157 Interleukin-2R antagonists in the prevention of acute rejection in living donor transplantation Ivanovski, N.
 2001
 33 7-8 p. 3203-3204
2 p.
 artikel
158 Interleukin-2 receptor monoclonal antibodies in renal transplantation: current use and emerging regimens Vincenti, F
 2001
 33 7-8 p. 3169-3171
3 p.
 artikel
159 Intestinal biotransformation of cyclosporine A in an extracorporeal pig intestine perfusion model Braun, F
 2001
 33 7-8 p. 3154-3155
2 p.
 artikel
160 Investigation of the relationship between maintenance dose of cyclosporine and nephrotoxicity or hypertension Opelz, G.
 2001
 33 7-8 p. 3351-3354
4 p.
 artikel
161 In vitro functional assessment of a porcine hepatocytes based bioartificial liver Donini, A.
 2001
 33 7-8 p. 3477-3479
3 p.
 artikel
162 Is losartan as effective as enalapril on posttransplant persistent proteinuria? Altiparmak, M.R
 2001
 33 7-8 p. 3368-3369
2 p.
 artikel
163 Is transjugular intrahepatic portosystemic shunt really deleterious for liver transplantation issue? a monocentric study on 86 liver transplanted patients Castellani, P.
 2001
 33 7-8 p. 3468-3469
2 p.
 artikel
164 Is transplantion of two HLA DR mismatched living-donor kidneys justifiable? Ozmen, M.M
 2001
 33 7-8 p. 3407-3408
2 p.
 artikel
165 Kaposi sarcoma: an analysis of the US and international experiences from the Israel Penn international transplant tumor registry Woodle, E.S.
 2001
 33 7-8 p. 3660-3661
2 p.
 artikel
166 Kidney transplantation from non-heart-beating donors 1 1 Cadaver donor Nicholson, M.L
 2001
 33 7-8 p. 3756-3758
3 p.
 artikel
167 Laparoscopic kidney harvesting for living donor kidney transplantation—one year follow-up of the initial 15 patients Giessing, M.
 2001
 33 7-8 p. 3791-3792
2 p.
 artikel
168 Laparoscopic live donor nephrectomy: a comparison with the open operation Waller, J.R.
 2001
 33 7-8 p. 3787-3788
2 p.
 artikel
169 Late failures in renal transplant recipients under cyclosporine treatment Ponticelli, C.
 2001
 33 7-8 p. 3325-3326
2 p.
 artikel
170 Leukocyte phagocytosis is impaired during kidney xenotransplantation Jaeger, K.
 2001
 33 7-8 p. 3869-3870
2 p.
 artikel
171 Leukocyte phenotype and function predicts infection risk in renal transplant recipients Blazic, M.
 2001
 33 7-8 p. 3651-
1 p.
 artikel
172 Liver retransplantations with split in situ grafts in pediatric recipients Maggi, U.
 2001
 33 7-8 p. 3614-
1 p.
 artikel
173 Liver transplantation in children with alagille syndrome Ganschow, R.
 2001
 33 7-8 p. 3608-3609
2 p.
 artikel
174 Liver transplantation today Klempnauer, J.
 2001
 33 7-8 p. 3433-3435
3 p.
 artikel
175 Liver transplantation using a 93-year-old donor Romagnoli, J.
 2001
 33 7-8 p. 3797-
1 p.
 artikel
176 Living donor liver transplantation: a critical review Emre, S.
 2001
 33 7-8 p. 3456-3457
2 p.
 artikel
177 Living donor lung transplantation: selection, technique, and outcome Barr, M.L.
 2001
 33 7-8 p. 3527-3532
6 p.
 artikel
178 Living orthotopic liver transplant using right lobe: our experience in the first 19 donors Cuomo, O.
 2001
 33 7-8 p. 3801-3802
2 p.
 artikel
179 Long-term effects of chronic cyclosporine nephropathy on outcome of renal allografts Takeda, A.
 2001
 33 7-8 p. 3379-3380
2 p.
 artikel
180 Long-term effects of single versus double CsA dosing in kidney transplantation Tarantino, A.
 2001
 33 7-8 p. 3409-3410
2 p.
 artikel
181 Long-term follow up of renal transplant artery stenosis by doppler Buturović-Ponikvar, J
 2001
 33 7-8 p. 3390-3391
2 p.
 artikel
182 Long-term outcome of cadaver kidney transplants from non-heart-beating donors Ohshima, S.
 2001
 33 7-8 p. 3764-3768
5 p.
 artikel
183 Long-term results of 211 single necrokidney transplantations from extreme-age donors: why dual allograft? Berardinelli, L
 2001
 33 7-8 p. 3774-3776
3 p.
 artikel
184 Long-term results of spousal renal donor transplants with donor-specific blood transfusions Miura, S
 2001
 33 7-8 p. 3417-3419
3 p.
 artikel
185 Long-term surveillance of heart-transplanted patients: noninvasive monitoring of acute rejection episodes and transplant vasculopathy Hummel, M
 2001
 33 7-8 p. 3539-3542
4 p.
 artikel
186 Low-dose immunosuppression with FK 506 and sirolimus after liver transplantation: 1-year results Pridöhl, O.
 2001
 33 7-8 p. 3229-3231
3 p.
 artikel
187 Low-dose sirolimus and tacrolimus in kidney transplantation: first results of a single-center experience Hartwig, T.
 2001
 33 7-8 p. 3226-3228
3 p.
 artikel
188 Low rate of acute rejection and cytomegalovirus infection in kidney transplant recipients with basiliximab Folkmane, I.
 2001
 33 7-8 p. 3209-3210
2 p.
 artikel
189 Malignant neoplastic disorders following long-term immunosuppression after orthotopic heart transplantation Tenderich, G.
 2001
 33 7-8 p. 3653-3655
3 p.
 artikel
190 Measuring intrarenal vascular resistance during machine perfusion preservation does not improve the assessment of renal viability made on clinical grounds Metcalfe, M.S.
 2001
 33 7-8 p. 3745-3746
2 p.
 artikel
191 Mechanism of action of the calcineurin inhibitors Halloran, P.F.
 2001
 33 7-8 p. 3067-3069
3 p.
 artikel
192 Medical evaluation for pancreas transplantation: evolving concepts Pirsch, J.D.
 2001
 33 7-8 p. 3489-3491
3 p.
 artikel
193 Molecular adsorbant recirculating system in patients with liver failure Lamesch, P.
 2001
 33 7-8 p. 3480-3482
3 p.
 artikel
194 Monoclonal antibody basiliximab with low cyclosporine dose as initial immunosuppression Boletis, J.N
 2001
 33 7-8 p. 3184-3186
3 p.
 artikel
195 Morbidity, mortality beyond the 10th year following heart transplant: data from a population of 163 patients Sebbag, L
 2001
 33 7-8 p. 3551-3552
2 p.
 artikel
196 Mycophenolate mofetil conversion or addition in patients with chronic progressive deterioration of renal allograft function Altaca, G.
 2001
 33 7-8 p. 3248-3249
2 p.
 artikel
197 Myocardial Na+/K+-ATPases and systolic heart hailure after transplantation Tran, N
 2001
 33 7-8 p. 3555-3557
3 p.
 artikel
198 Neoral-based immunosuppression in living donor liver transplantation Takatsuki, M.
 2001
 33 7-8 p. 3450-
1 p.
 artikel
199 Neoral C2 in liver transplant recipients Levy, G.A
 2001
 33 7-8 p. 3089-3091
3 p.
 artikel
200 Neoral C2 monitoring in pediatric liver transplant recipients Dunn, S.
 2001
 33 7-8 p. 3094-3095
2 p.
 artikel
201 Neoral dose monitoring with cyclosporine 2-hour postdose levels (C2) in different renal transplant patient age groups Rosati, A.
 2001
 33 7-8 p. 3106-3107
2 p.
 artikel
202 Neoral drug monitoring in stable kidney allotransplant recipients: C0 versus C2 Lukaschek, J.
 2001
 33 7-8 p. 3104-3105
2 p.
 artikel
203 New approaches to paediatric liver transplantation Kelly, D.A.
 2001
 33 7-8 p. 3602-3603
2 p.
 artikel
204 New developments in pancreas and islet transplantation Squifflet, J.-P.
 2001
 33 7-8 p. 3492-3493
2 p.
 artikel
205 New frontiers: adult to adult living donor liver transplantation, single center experience from turkey Tokat, Y.
 2001
 33 7-8 p. 3458-3460
3 p.
 artikel
206 New immunosuppressive regimens and cytomegalovirus infection after kidney transplantation: a retrospective study Côté, I
 2001
 33 7-8 p. 3626-3629
4 p.
 artikel
207 Newly developing proteinuria but not blood pressure is an independent risk factor for chronic graft dysfunction following renal transplantation in patients with well-controlled blood pressure Braun, N.
 2001
 33 7-8 p. 3361-3362
2 p.
 artikel
208 New trends in heart transplantation Gambino, A.
 2001
 33 7-8 p. 3536-3538
3 p.
 artikel
209 NF-κB antisense oligonucleotides reduce leukocyte-endothelial interaction in hepatic ischemia-reperfusion Banafsche, R
 2001
 33 7-8 p. 3726-3727
2 p.
 artikel
210 NKT Cells as nonspecific immune-regulator inducing tolerance in mouse model transplantation Chargui, J.
 2001
 33 7-8 p. 3833-3834
2 p.
 artikel
211 Normothermic perfusion of ischaemically damaged porcine kidneys: an evaluation of ex vivo function Metcalfe, M.S.
 2001
 33 7-8 p. 3743-3744
2 p.
 artikel
212 Normothermic perfusion of the isolated liver Friend, P.J.
 2001
 33 7-8 p. 3436-3438
3 p.
 artikel
213 Nutritional status in renal transplant recipients, evaluated by means of body composition analysis Lucchesi, A.
 2001
 33 7-8 p. 3398-3399
2 p.
 artikel
214 Obese kidney transplant recipients have good outcomes Howard, R.J
 2001
 33 7-8 p. 3420-3421
2 p.
 artikel
215 Optimal time for determination of blood tacrolimus level Jørgensen, K.A.
 2001
 33 7-8 p. 3164-3165
2 p.
 artikel
216 Optimization of cyclosporine exposure utilizing C2 level monitoring in de novo renal transplant recipients: the toronto general hospital experience Maham, N.
 2001
 33 7-8 p. 3098-3099
2 p.
 artikel
217 Optimization of cyclosporine therapy in the neoral era: abbreviated AUC, single blood sampling? Gaspari, F.
 2001
 33 7-8 p. 3117-3119
3 p.
 artikel
218 Optimizing neoral therapeutic drug monitoring with cyclosporine trough (C0) and C2 concentrations in stable renal allograft recipients Einecke, G
 2001
 33 7-8 p. 3102-3103
2 p.
 artikel
219 Outcome of renal transplants in patients with IgA nephropathy Koselj-Kajtna, M.
 2001
 33 7-8 p. 3429-3430
2 p.
 artikel
220 Overseas procurement of donor hearts: ischemic time effect on postoperative outcomes Fernandez, J
 2001
 33 7-8 p. 3803-3804
2 p.
 artikel
221 Oxygen profile of microencapsulated islets: effect of immobilised hemoglobin in the alginate matrix Schrezenmeir, J
 2001
 33 7-8 p. 3511-3516
6 p.
 artikel
222 Pancreas and islet transplantation: an unfinished journey Allen, R.D.M.
 2001
 33 7-8 p. 3485-3488
4 p.
 artikel
223 Pancreas transplantation in Asan Medical Center, Korea Han, D.J.
 2001
 33 7-8 p. 3499-
1 p.
 artikel
224 Partial splenic embolization for hypersplenism after liver transplantation Sockrider, C.S.
 2001
 33 7-8 p. 3472-3473
2 p.
 artikel
225 Pathologic characteristics of acute humoral rejection after abo-incompatible kidney transplantation Morozumi, K.
 2001
 33 7-8 p. 3299-3300
2 p.
 artikel
226 Pediatric renal transplantation Harmon, W.
 2001
 33 7-8 p. 3585-3586
2 p.
 artikel
227 Pediatric renal transplantation: experience from a center in central Anatolia Duzova, A.
 2001
 33 7-8 p. 3597-3598
2 p.
 artikel
228 Perioperative donor bone marrow infusion in cadaver kidney transplant recipients Garcia-Morales, R.O.
 2001
 33 7-8 p. 3840-3843
4 p.
 artikel
229 Persistent hyperglycemia in pediatric liver transplant recipients Romero, R.
 2001
 33 7-8 p. 3617-3618
2 p.
 artikel
230 Pharmacodynamic monitoring of lymphocyte proliferation and TGF-β1 expression at cyclosporine a (CyA) trough levels (C0) and 2 hours after intake (C2) of CyA in human renal allograft recipients Böhler, T.
 2001
 33 7-8 p. 3148-3150
3 p.
 artikel
231 Pharmacodynamic monitoring of mycophenolate mofetil in renal allograft recipients Budde, K.
 2001
 33 7-8 p. 3313-3315
3 p.
 artikel
232 Pharmacoeconomic evaluation of simulect prophylaxis in renal transplant recipients Walters, S.J
 2001
 33 7-8 p. 3187-3191
5 p.
 artikel
233 Pharmacokinetics and pharmacodynamics of a chimeric interleukin-2 receptor monoclonal antibody, basiliximab, in renal transplantation: a comparison between Japanese and non-Japanese patients Haba, T.
 2001
 33 7-8 p. 3174-3175
2 p.
 artikel
234 Phosphorothioate/methoxyethyl-modified ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injury 1 1 Renal Stepkowski, S.M.
 2001
 33 7-8 p. 3705-3706
2 p.
 artikel
235 Physiologic regulation of alloimmune responses in vivo: the role of CTLA4 and TH1/TH2 cytokines Sho, M.
 2001
 33 7-8 p. 3826-3828
3 p.
 artikel
236 PNU156804 inhibits Jak3 tyrosine kinase and rat heart allograft rejection Stepkowski, S.M.
 2001
 33 7-8 p. 3272-3273
2 p.
 artikel
237 Posttransplant diabetes mellitus in renal allograft recipients Koselj, M.
 2001
 33 7-8 p. 3662-3663
2 p.
 artikel
238 Preemptive oral ganciclovir therapy versus prophylaxis to prevent symptomatic cytomegalovirus infection after kidney transplantation Jung, C
 2001
 33 7-8 p. 3621-3623
3 p.
 artikel
239 Pretreatment with magnolol attenuates ischemia-reperfusion injury in rat small intestine Loong, C.C.
 2001
 33 7-8 p. 3737-3738
2 p.
 artikel
240 Prevention of hyperacute rejection of pig-to-monkey cardiac xenografts by chinese cobra venom factor Chen, G.
 2001
 33 7-8 p. 3857-3858
2 p.
 artikel
241 Primary nonfunctioning graft in cadaveric renal transplantation Castilho, C.
 2001
 33 7-8 p. 3785-3786
2 p.
 artikel
242 Prognosis in patients with primary pulmonary hypertension awaiting lung transplantation Ewert, R.
 2001
 33 7-8 p. 3574-3575
2 p.
 artikel
243 Progression of chronic renal transplant dysfunction Fellström, B.
 2001
 33 7-8 p. 3355-3356
2 p.
 artikel
244 Prospective analysis and successful treatment of thrombotic microangiopathy in renal allografts under tacrolimus immunosuppression Tanabe, K
 2001
 33 7-8 p. 3688-3690
3 p.
 artikel
245 Prostaglandin E1 inhibits cyclosporine A-induced upregulation of transforming growth factor-beta 1 in rat mesangial cells Dell, K.
 2001
 33 7-8 p. 3342-3344
3 p.
 artikel
246 Protective effect of a selective endothelin a receptor antagonist (BSF 208075) on graft pancreatitis in pig pancreas transplantation Uhlmann, D
 2001
 33 7-8 p. 3732-3734
3 p.
 artikel
247 Protective Effects of Polyethylene Glycol (20 mol/L) in Phosphate-Buffered Sucrose for Rat Liver Preservation Ahmed, I
 2001
 33 7-8 p. 3713-3715
3 p.
 artikel
248 Proteinuria as a useful clinical marker of cyclosporine nephrotoxicity in renal transplant patients Fernández-Fresnedo, G
 2001
 33 7-8 p. 3373-3374
2 p.
 artikel
249 Proteinuria at five years after kidney transplantation: the role of anti-HCV-positive state Virgilio, B.
 2001
 33 7-8 p. 3639-3640
2 p.
 artikel
250 Psychiatric complications after liver transplantation Kizilisik, A.T.
 2001
 33 7-8 p. 3697-
1 p.
 artikel
251 Psychiatric symptoms in renal transplant patients in relation to alexithymia Kubo, M.
 2001
 33 7-8 p. 3698-3699
2 p.
 artikel
252 Purity of alginate affects the viability and fibrotic overgrowth of encapsulated porcine islet xenografts Zhang, W.J.
 2001
 33 7-8 p. 3517-3519
3 p.
 artikel
253 Pyruvate improves pancreatic islet engraftment and functionality Brown, M.
 2001
 33 7-8 p. 3523-
1 p.
 artikel
254 Quality of life after heart and heart-lung transplantation Hummel, M
 2001
 33 7-8 p. 3546-3548
3 p.
 artikel
255 Quality of life for renal transplant recipients of organs from non-heart-beating donors, heart-beating cadaveric donors, and living-related donors Metcalfe, M.S
 2001
 33 7-8 p. 3403-3404
2 p.
 artikel
256 Quality of life of pediatric patients receiving living donor liver transplantation in long-term follow-up period Ohkohchi, N.
 2001
 33 7-8 p. 3610-3613
4 p.
 artikel
257 Rapamycin reduces rejection in heart transplant recipients Radovancevic, B.
 2001
 33 7-8 p. 3221-3222
2 p.
 artikel
258 Recipient age affects chronic allograft nephropathy in rats Wang, M.
 2001
 33 7-8 p. 3341-
1 p.
 artikel
259 Refining immunosuppressive protocols in pediatric renal transplant recipients Hoyer, P.F.
 2001
 33 7-8 p. 3587-3589
3 p.
 artikel
260 Renal allograft surveillance by mRNA profiling of urinary cells Li, B
 2001
 33 7-8 p. 3280-3282
3 p.
 artikel
261 Renal function after liver transplantation Bäckman, L
 2001
 33 7-8 p. 3442-3443
2 p.
 artikel
262 Renal transplantation from marginal donors: results and allocation strategies Persson, N.H.
 2001
 33 7-8 p. 3759-3761
3 p.
 artikel
263 Renal transplantation from older donors Tarantino, A
 2001
 33 7-8 p. 3769-3770
2 p.
 artikel
264 Renal transplantation in amyloidosis secondary to familial Mediterranean fever Sever, M.S.
 2001
 33 7-8 p. 3392-3393
2 p.
 artikel
265 Renal transplantation in children less than six years old Garcia, C.D.
 2001
 33 7-8 p. 3595-3596
2 p.
 artikel
266 Renal transplantation with simulect (basiliximab) plus sandimmune neoral-based immunosuppression: a report of 41 cases in Taiwan Tsai, M.K.
 2001
 33 7-8 p. 3194-
1 p.
 artikel
267 Reversal of streptozotocin-diabetes after transplantation of piscine principal islets to nude mice Laue, C
 2001
 33 7-8 p. 3504-3510
7 p.
 artikel
268 Risk factors that influence the intercept or the slope of graft function over time Paul, L.C.
 2001
 33 7-8 p. 3359-3360
2 p.
 artikel
269 Role of ACE gene polymorphism on cardiovascular complications after renal transplantation Hernández, D
 2001
 33 7-8 p. 3686-3687
2 p.
 artikel
270 Role of ischemia-reperfusion injury in the development of chronic renal allograft damage Grinyo, J.M.
 2001
 33 7-8 p. 3741-3742
2 p.
 artikel
271 Serum antibody activity to glomerular endothelial cells is a useful indication for renal allograft rejection Nakagawa, Y.
 2001
 33 7-8 p. 3289-3292
4 p.
 artikel
272 Seventeen adult-to-adult living donor liver transplantations using dual grafts Lee, S.G
 2001
 33 7-8 p. 3461-3463
3 p.
 artikel
273 Severe neurotoxicity of tacrolimus (FK506) after renal transplantation: two case reports Scheel, A.K.
 2001
 33 7-8 p. 3693-3694
2 p.
 artikel
274 Short-term outcome of dual kidney transplantation at a single center Rigotti, P
 2001
 33 7-8 p. 3771-3773
3 p.
 artikel
275 Simulect, calcineurin inhibitor, mycophenolate mofetil, and prednisone is more effective than OKT3, calcineurin inhibitor, hycophendate mofetil, and prednisone in African American kidney recipients in reducing acute rejections and prolonging graft survival Kumar, A.M.S
 2001
 33 7-8 p. 3195-3196
2 p.
 artikel
276 Simulect, neoral, cellcept, and prednisone in kidney recipients with delayed graft function: a prospective controlled study Kumar, M.S.A
 2001
 33 7-8 p. 3762-3763
2 p.
 artikel
277 Simultaneous pancreas-kidney transplant compared with kidney transplant in Type I diabetic patients with end-stage renal disease Pérez, R.
 2001
 33 7-8 p. 3494-3495
2 p.
 artikel
278 Simultaneous transplantation model of the aorta and carotid in rats Chen, Z.S.
 2001
 33 7-8 p. 3824-3825
2 p.
 artikel
279 Single-center experience with the “old for old” program for renal transplantation Beckurts, U.T.E.
 2001
 33 7-8 p. 3779-3780
2 p.
 artikel
280 Single-center study utilizing C2 level as monitoring tool in de novo renal transplant recipients treated with neoral Keshavamurthy, M.
 2001
 33 7-8 p. 3112-3114
3 p.
 artikel
281 Sirolimus and low-dose tacrolimus with antibody induction in kidney transplantation: preliminary results of a pilot study Lawen, J
 2001
 33 7-8 p. 3223-3225
3 p.
 artikel
282 Solid organ transplantation in HIV-positive patients Stock, P.
 2001
 33 7-8 p. 3646-3648
3 p.
 artikel
283 Steps toward transplantation tolerance in the clinic Knechtle, S.J.
 2001
 33 7-8 p. 3844-3845
2 p.
 artikel
284 Steroid-free immunosuppression Ponticelli, C.
 2001
 33 7-8 p. 3259-3260
2 p.
 artikel
285 Steroid withdrawal in long-term cyclosporine a treated patients using mycophenolate mofetil: a prospective randomized pilot study Budde, K
 2001
 33 7-8 p. 3250-3252
3 p.
 artikel
286 Steroid withdrawal in long-term liver transplant recipients Sterneck, M
 2001
 33 7-8 p. 3265-3267
3 p.
 artikel
287 Steroid withdrawal in renal transplanation Hricik, D.E.
 2001
 33 7-8 p. 3261-3262
2 p.
 artikel
288 Steroid withdrawal in renal transplantation treated with cyclosporine a: long-term evolution Gómez, E.
 2001
 33 7-8 p. 3263-3264
2 p.
 artikel
289 Study of simulect-based, steroid-free immunosuppressive regimen in HCV+ de novo liver transplant patients: preliminary results Filipponi, F
 2001
 33 7-8 p. 3211-3212
2 p.
 artikel
290 Study of the cyclosporine concentration at 2 hours in stable renal transplant patients and relation to body mass index Hortal, L
 2001
 33 7-8 p. 3110-3111
2 p.
 artikel
291 Successful hepatitis B reinfection prophylaxis with lamivudine and hepatitis B immune globulin in patients with positive HBV-DNA at time of liver transplantation Rosenau, J.
 2001
 33 7-8 p. 3637-3638
2 p.
 artikel
292 Successful pediatric kidney transplantation from pediatric Non-Heart-Beating Donors Saito, K.
 2001
 33 7-8 p. 3781-3782
2 p.
 artikel
293 Suppression of kupffer cell function is a key for liver transplantation from the non-heart-beating donor Ohkohchi, N.
 2001
 33 7-8 p. 3728-3731
4 p.
 artikel
294 Surgical management of high-grade vesicoureteral reflux in renal transplant recipients Kmetec, A.
 2001
 33 7-8 p. 3383-3384
2 p.
 artikel
295 Surgical options for live-donor nephrectomy Velidedeoglu, E
 2001
 33 7-8 p. 3789-3790
2 p.
 artikel
296 Survival after liver transplantation for hepatocellular carcinoma in cirrhosis according to the underlying liver disease Jonas, S.
 2001
 33 7-8 p. 3444-3445
2 p.
 artikel
297 Targeting Jak3 for immune suppression and allograft acceptance Kirken, R.A.
 2001
 33 7-8 p. 3268-3270
3 p.
 artikel
298 T-cell apoptosis triggered by FTY720 via mitochondrial pathway Fujino, M.
 2001
 33 7-8 p. 3084-3085
2 p.
 artikel
299 T-Cell-Mediated immune response is crucial for hamster-to-mouse cardiac xenograft rejection Zhu, T.
 2001
 33 7-8 p. 3823-
1 p.
 artikel
300 Ten years of chronic immunosuppressive therapy following orthotopic liver transplantation: impact on health and quality of life Kizilisik, A.T.
 2001
 33 7-8 p. 3448-3449
2 p.
 artikel
301 The Buffalo/Mna rat, an animal model of FSGS recurrence after renal transplantation Le Berre, L.
 2001
 33 7-8 p. 3338-3340
3 p.
 artikel
302 The development of tacrolimus in renal transplantation Shapiro, R.
 2001
 33 7-8 p. 3158-3160
3 p.
 artikel
303 The effect of kidney transplantation on autonomic nervous dysfunction in patients with chronic renal failure Kveder, R
 2001
 33 7-8 p. 3394-3395
2 p.
 artikel
304 The effects of rejection episodes, obesity, and osteopenia on functional performance and health-related quality of life after heart transplantation Streiff, N
 2001
 33 7-8 p. 3533-3535
3 p.
 artikel
305 The efficacy and safety of mizoribine in living donor kidney transplantation: a 24-week, open-label, prospective study (phase III clinical trial) Cho, D.K.
 2001
 33 7-8 p. 3256-3258
3 p.
 artikel
306 The enigma of tolerance and chimerism: variable role of t cells and chimerism in induction of tolerance with bone marrow Monaco, A.P.
 2001
 33 7-8 p. 3837-3839
3 p.
 artikel
307 The evolution of therapeutic drug monitoring of cyclosporine 1 1 Concentration monitoring Kahan, B.D.
 2001
 33 7-8 p. 3086-3088
3 p.
 artikel
308 The evolving role of tor inhibitors for individualizing posttransplant immunosuppression Lorber, M.I.
 2001
 33 7-8 p. 3075-3077
3 p.
 artikel
309 The α-gal analog GAS914 ameliorates delayed rejection of hDAF transgenic pig-to-baboon renal xenografts Ghanekar, A.
 2001
 33 7-8 p. 3853-3854
2 p.
 artikel
310 The IL2 pathway in clinical immunosuppression Nashan, B.
 2001
 33 7-8 p. 3072-3074
3 p.
 artikel
311 The matrix of clinical immunosuppression for transplantation Kahan, B.D.
 2001
 33 7-8 p. 3035-3037
3 p.
 artikel
312 The new “impella” intracardiac microaxial pump for treatment of right heart failure after orthotopic heart transplantation Martin, J.
 2001
 33 7-8 p. 3549-3550
2 p.
 artikel
313 The present status of xenotransplantation Levy, G.A.
 2001
 33 7-8 p. 3050-3052
3 p.
 artikel
314 Therapeutic equivalence of mycophenolate sodium versus mycophenolate mofetil in de novo renal transplant recipients 1 1 For the ERLB301 Renal Transplant Study Group. Salvadori, M
 2001
 33 7-8 p. 3245-3247
3 p.
 artikel
315 The role of adhesion molecules and chemokines in homeostasis and pathologic processes in transplanted organs Stepkowski, S.M.
 2001
 33 7-8 p. 3064-3066
3 p.
 artikel
316 The role of certican (everolimus, rad) in the many pathways of chronic rejection Nashan, B
 2001
 33 7-8 p. 3215-3220
6 p.
 artikel
317 The role of signals 1, 2, and 3 in induction of transplantation tolerance Stepkowski, S.M.
 2001
 33 7-8 p. 3831-3832
2 p.
 artikel
318 The role of Stat5 in the induction of regulatory t cells in transplantation tolerance Stepkowski, S.M.
 2001
 33 7-8 p. 3835-3836
2 p.
 artikel
319 The value of dynamic enhanced MRI in the early diagnosis of hip pain in patients having received marrow transplantation Tan, C.F.
 2001
 33 7-8 p. 3670-3671
2 p.
 artikel
320 The value of renal resistive index for the detection of vesicoureteral reflux in renal transplant recipients Kmetec, A
 2001
 33 7-8 p. 3385-3387
3 p.
 artikel
321 Three-hour postdose cyclosporine level monitoring: less rejection and more nephrotoxicity? Domı́nguez, J.
 2001
 33 7-8 p. 3120-3121
2 p.
 artikel
322 Time to request ABO-identity when transplanting for fulminant hepatic failure? Ericzon, B.-G
 2001
 33 7-8 p. 3466-3467
2 p.
 artikel
323 Tissue concentration of cytokines in kidneys from non-heart-beating donors Tŕeška, V.
 2001
 33 7-8 p. 3747-3749
3 p.
 artikel
324 T-lymphocyte kinetics in acute rejection after orthotopic liver transplantation Cuomo, O.
 2001
 33 7-8 p. 3303-
1 p.
 artikel
325 TNF:TNF-R T-Cell costimulatory pathways in transplantation Yamada, A.
 2001
 33 7-8 p. 3070-3071
2 p.
 artikel
326 Transplantation of small en bloc kidneys including a horseshoe kidney from donors aged 2 to 60 months to adult recipients: a 13-year experience Merkel, F.K
 2001
 33 7-8 p. 3783-3784
2 p.
 artikel
327 Transplantation tolerance—discussion Wood, K.J.
 2001
 33 7-8 p. 3819-3820
2 p.
 artikel
328 Treatment of reccurence of focal segmental glomerular sclerosis after kidney transplantation with plasma exchange and immunoadsorption Ponikvar, R
 2001
 33 7-8 p. 3365-3367
3 p.
 artikel
329 Treatment of severe pneumonia in kidney transplant recipients Benedetti, E.
 2001
 33 7-8 p. 3652-
1 p.
 artikel
330 Treatment with rabbit antithymocyte serum permits a cyclophosphamide-free approach to prevention of hdaf transgenic porcine kidney xenograft rejection in baboons Ghanekar, A.
 2001
 33 7-8 p. 3849-3850
2 p.
 artikel
331 Tubular cells trans-differentiation induced by allogenic response can be modulated by cyclo-oxygenase-2 inhibitors Peruzzi, L.
 2001
 33 7-8 p. 3349-3350
2 p.
 artikel
332 Twenty-year graft survival of living-related kidney transplantation in a single center Ohmori, Y.
 2001
 33 7-8 p. 3414-3415
2 p.
 artikel
333 Update from studies in pediatric liver transplantation McDiarmid, S.V.
 2001
 33 7-8 p. 3604-3605
2 p.
 artikel
334 Urolithiasis/calcinations in renal graft—a link with renal transplant bone disease treatment? Ponikvar, J.B.
 2001
 33 7-8 p. 3672-3673
2 p.
 artikel
335 Usefulness of finger thermography to assess cyclosporine toxicity after heart transplantation Doutreleau, S.
 2001
 33 7-8 p. 3318-3319
2 p.
 artikel
336 Usefulness of IgM anti-HCV in differential diagnosis between recurrent hepatitis C and acute rejection in liver transplant patients Ciccorossi, P
 2001
 33 7-8 p. 3641-3642
2 p.
 artikel
337 Usefulness of two-point AUC0–4 monitoring in maintenance renal transplant patients Uchida, K
 2001
 33 7-8 p. 3128-3130
3 p.
 artikel
338 Use of A2 kidneys for B and O kidney transplant recipients: report of a series of patients transplanted at a single center spanning a decade Norman, D.J
 2001
 33 7-8 p. 3327-3330
4 p.
 artikel
339 Use of basiliximab in conjunction with either Neora/MMF/steroids or Prograf/MMF/steroids in simultaneous pancreas-kidney transplantation Boggi, U
 2001
 33 7-8 p. 3201-3202
2 p.
 artikel
340 Use of isolated perfused rat liver model for testing liver preservation solutions Ahmed, I
 2001
 33 7-8 p. 3709-3711
3 p.
 artikel
341 Use of laser doppler as a noninvasive measure of ischemia-reperfusion injury in the pig liver Imber, C.J.
 2001
 33 7-8 p. 3718-3719
2 p.
 artikel
342 Vascular anomalies associated with biliary atresia in pretransplant survey Chen, T.Y.
 2001
 33 7-8 p. 3470-3471
2 p.
 artikel
343 Within-patient controlled assessment of the influence of basiliximab on cyclosporine in pediatric de novo renal transplant recipients Kovarik, J.M
 2001
 33 7-8 p. 3172-3173
2 p.
 artikel
344 Xenoreactivity of human natural antibodies with various porcine pancreatic cells Zhang, W.J
 2001
 33 7-8 p. 3865-3866
2 p.
 artikel
                             344 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland